AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Alexandria Real Estate Equities, Inc.

$51.14 +$2.17 (+4.43%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$49.56
Day Range
$49.23$51.18
Year Range
$39.41$88.24
Market Cap
8.91B
AVG Volume
1.92M
Trailing/Forward PE
-9.18/-
PEG ratio
0.06
Dividend Yield
6.80%
Next Earnings Date
2026-10-26
Primary Exchange
New York Stock ExchangeUS
Revenue (USD) · TTM
01B2B3B4B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARE Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q22.96B
26 Q12.9B
25 Q42.97B
25 Q32.98B
25 Q23.02B
25 Q13.04B
24 Q43.05B
24 Q33.03B
24 Q22.96B
24 Q12.91B
Net Income (USD) · TTM
-1.5B-1B-500M0500M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARE Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2-904M
26 Q1-1.02B
25 Q4-1.43B
25 Q3-410.94M
25 Q2-10.24M
25 Q1143.47M
24 Q4322.95M
24 Q3296.76M
24 Q2153.09M
24 Q1196.32M
Operating Income (USD) · TTM
-2B-1B01B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARE Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2-1.35B
26 Q1-1.24B
25 Q4-1.2B
25 Q3568.78M
25 Q2646.15M
25 Q1711.12M
24 Q4769.7M
24 Q3785.1M
24 Q2755.05M
24 Q1725.56M
EBITDA (USD) · TTM
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARE EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2425.62M
26 Q1405.64M
25 Q4360.45M
25 Q31.34B
25 Q21.69B
25 Q11.78B
24 Q41.9B
24 Q31.78B
24 Q21.55B
24 Q11.52B
Cash Flows (USD) · TTM
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARE Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2876.13M
26 Q11.4B
25 Q41.41B
25 Q31.38B
25 Q21.42B
25 Q11.37B
24 Q41.5B
24 Q31.27B
24 Q21.21B
24 Q11.27B
EPS (USD) · TTM
-10-50524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARE EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q2-5.56
26 Q1-6.27
25 Q4-8.44
25 Q3-2.47
25 Q2-0.13
25 Q10.76
24 Q41.8
24 Q34.47
24 Q23.64
24 Q13.49
Expenses (USD) · TTM
0200M400M600MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARE Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q2532.11M
26 Q1121.06M
25 Q4117.05M
25 Q3121.76M
25 Q2136.48M
25 Q1151.98M
24 Q4168.36M
24 Q3586.21M
24 Q2588.25M
24 Q1589.5M
Shares Outstanding (USD) · TTM
-100M0100M200M300MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARE Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-28.77M
26 Q1-30.44M
25 Q4178.72M
25 Q3224.58M
25 Q2227.06M
25 Q1227.43M
24 Q436.14M
24 Q3-36.08M
24 Q2-47.81M
24 Q1-47.18M
Dividends (USD)
00.511.5Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
ARE Dividends (USD) by quarter
PeriodDividends (USD)
Sep 260.72
Jun 260.72
Mar 260.72
Dec 250.72
Sep 251.32
Jun 251.32
Mar 251.32
Dec 241.32
Sep 241.3
Jun 241.3
Employee Count
02004006002016201720182019202020212022202320242025
ARE Employee Count by quarter
PeriodEmployee Count
2025514
2024552
2023568
2022593
2021559
2020470
2019439
2018386
2017323
2016285
PE Ratio
050100150200250med 86.42Oct 23Feb 24May 24Sep 24Dec 24Apr 25Jul 25
ARE PE Ratio by quarter
PeriodPE Ratio
Jul 2592.91
Jul 2594.55
Jul 2591.43
Jun 2587.21
Jun 2584.83
Jun 2585.71
Jun 2583.83
May 2583.43
May 2580.62
May 2586.59
May 2588.04
May 2588.51
Apr 2540.43
Apr 2541.47
Apr 2540.98
Apr 2543.3
Mar 2550.93
Mar 2551.29
Mar 2552.83
Mar 2554.6
Feb 2554.48
Feb 2550.92
Feb 2550.53
Feb 2551.12
Jan 2551.87
Jan 2558.92
Jan 2559.02
Jan 2555.07
Jan 2557.49
Dec 2457.02
Dec 2457.5
Dec 2459.52
Dec 2460.21
Nov 2463.91
Nov 2462.79
Nov 2461.21
Nov 2466.12
Nov 2464.27
Oct 2465.53
Oct 24136.85
Oct 24132.14
Oct 24129.1
Sep 24135.98
Sep 24136.24
Sep 24139.8
Sep 24130.67
Aug 24134.35
Aug 24136.18
Aug 24128.87
Aug 24127.7
Aug 24127.37
Jul 24133.62
Jul 24109.67
Jul 24110.37
Jul 24102.3
Jun 24102.45
Jun 24102.09
Jun 24101.88
Jun 24100.28
May 24104.23
May 24103.7
May 24108.75
May 24106.49
May 24105.55
Apr 24101.81
Apr 24190.99
Apr 24201.14
Apr 24205.67
Mar 24212.82
Mar 24207.24
Mar 24204.3
Mar 24209.94
Mar 24205.16
Feb 24201.29
Feb 24196.92
Feb 24191.83
Feb 24200.52
Jan 2486.25
Jan 2485.55
Jan 2487.56
Jan 2487.75
Dec 2387.93
Dec 2388.61
Dec 2390.26
Dec 2382.84
Dec 2381.94
Nov 2372.95
Nov 2371.94
Nov 2366.35
Nov 2370.97
Oct 2363.57
Oct 2328.66
Oct 2329.81
Oct 2329.47
Sep 2330.17
Sep 2330.52
Sep 2334.28
Sep 2334.67
Sep 2335.25
Aug 2334.77
Free Cash Flow Yield
5%10%15%20%med 11.14%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARE Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 269.09%
Sep 268.83%
Aug 269.02%
Aug 268.69%
Aug 269.66%
Aug 269.35%
Jul 2614.47%
Jul 2614.62%
Jul 2614.83%
Jul 2615.55%
Jul 2614.16%
Jun 2613.48%
Jun 2614.59%
Jun 2614%
Jun 2614.52%
May 2614.99%
May 2615.39%
May 2616.56%
May 2616.1%
May 2617.99%
Apr 2617.51%
Apr 2617.06%
Apr 2619.48%
Apr 2619.2%
Mar 2618.02%
Mar 2617.51%
Mar 2617.14%
Mar 2616.36%
Feb 2615.36%
Feb 2615.47%
Feb 2615.81%
Feb 2614.85%
Jan 2615.19%
Jan 2613.55%
Jan 2613.97%
Jan 2614.98%
Jan 2616.51%
Dec 2516.64%
Dec 2516.87%
Dec 2517.34%
Dec 2517.78%
Nov 2515.07%
Nov 2515.89%
Nov 2515.47%
Nov 2514.54%
Oct 2513.89%
Oct 2510.78%
Oct 2511.13%
Oct 2511.29%
Oct 259.96%
Sep 259.95%
Sep 259.68%
Sep 259.83%
Sep 259.85%
Aug 2510.12%
Aug 2510.31%
Aug 2510.97%
Aug 2511.24%
Aug 2510.98%
Jul 2510.15%
Jul 2510.29%
Jul 2510.11%
Jul 2510.45%
Jun 2510.96%
Jun 2511.27%
Jun 2511.15%
Jun 2511.4%
May 2511.46%
May 2511.86%
May 2511.04%
May 2510.86%
May 2510.8%
Apr 2511.52%
Apr 2511.23%
Apr 2511.37%
Apr 2510.76%
Mar 259.15%
Mar 259.08%
Mar 258.82%
Mar 258.53%
Feb 258.55%
Feb 259.15%
Feb 259.22%
Feb 259.11%
Jan 258.98%
Jan 257.25%
Jan 257.24%
Jan 257.76%
Jan 257.43%
Dec 247.49%
Dec 247.43%
Dec 247.18%
Dec 247.09%
Nov 246.68%
Nov 246.8%
Nov 246.98%
Nov 246.46%
Nov 246.65%
Oct 246.52%
Oct 245.77%
Price to Sales
2468med 4.03Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARE Price to Sales by quarter
PeriodPrice to Sales
Sep 263.26
Sep 263.35
Aug 263.29
Aug 263.41
Aug 263.07
Aug 263.17
Jul 263.34
Jul 263.31
Jul 263.26
Jul 263.11
Jul 263.42
Jun 263.59
Jun 263.32
Jun 263.46
Jun 263.33
May 263.23
May 263.14
May 262.92
May 263.01
May 262.69
Apr 262.72
Apr 262.79
Apr 262.44
Apr 262.48
Mar 262.64
Mar 262.72
Mar 262.78
Mar 262.91
Feb 263.1
Feb 263.08
Feb 263.01
Feb 263.21
Jan 263.13
Jan 263.41
Jan 263.31
Jan 263.08
Jan 262.8
Dec 252.78
Dec 252.74
Dec 252.66
Dec 252.6
Nov 253.06
Nov 252.91
Nov 252.99
Nov 253.18
Oct 253.32
Oct 254.36
Oct 254.23
Oct 254.17
Oct 254.72
Sep 254.72
Sep 254.86
Sep 254.78
Sep 254.77
Aug 254.65
Aug 254.56
Aug 254.29
Aug 254.18
Aug 254.28
Jul 254.63
Jul 254.39
Jul 254.47
Jul 254.32
Jun 254.12
Jun 254.01
Jun 254.05
Jun 253.96
May 253.94
May 253.81
May 254.09
May 254.16
May 254.18
Apr 254.28
Apr 254.39
Apr 254.34
Apr 254.59
Mar 255.39
Mar 255.43
Mar 255.59
Mar 255.78
Feb 255.77
Feb 255.39
Feb 255.35
Feb 255.41
Jan 255.49
Jan 255.77
Jan 255.78
Jan 255.4
Jan 255.63
Dec 245.59
Dec 245.63
Dec 245.83
Dec 245.9
Nov 246.26
Nov 246.15
Nov 246
Nov 246.48
Nov 246.3
Oct 246.42
Oct 247.08
EV/EBITDA
020406080med 16.79Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARE EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2651.63
Sep 2652.3
Aug 2651.82
Aug 2652.67
Aug 2650.31
Aug 2651.01
Jul 2654.61
Jul 2654.37
Jul 2654.04
Jul 2652.95
Jul 2655.13
Jun 2656.36
Jun 2654.41
Jun 2655.41
Jun 2654.53
May 2653.79
May 2653.18
May 2651.6
May 2652.2
May 2649.94
Apr 2656.29
Apr 2656.87
Apr 2654.02
Apr 2654.32
Mar 2655.64
Mar 2656.28
Mar 2656.76
Mar 2657.86
Feb 2659.43
Feb 2659.24
Feb 2658.69
Feb 2660.31
Jan 2659.71
Jan 2617.59
Jan 2617.36
Jan 2616.86
Jan 2616.23
Dec 2516.18
Dec 2516.1
Dec 2515.93
Dec 2515.78
Nov 2516.82
Nov 2516.47
Nov 2516.65
Nov 2517.07
Oct 2517.4
Oct 2515.55
Oct 2515.31
Oct 2515.2
Oct 2516.19
Sep 2516.2
Sep 2516.43
Sep 2516.31
Sep 2516.28
Aug 2516.06
Aug 2515.91
Aug 2515.42
Aug 2515.23
Aug 2515.41
Jul 2516.03
Jul 2514.76
Jul 2514.89
Jul 2514.64
Jun 2514.3
Jun 2514.11
Jun 2514.18
Jun 2514.03
May 2514
May 2513.77
May 2514.25
May 2514.37
May 2514.41
Apr 2513.3
Apr 2513.48
Apr 2513.39
Apr 2513.79
Mar 2515.09
Mar 2515.15
Mar 2515.41
Mar 2515.71
Feb 2515.69
Feb 2515.08
Feb 2515.02
Feb 2515.12
Jan 2515.24
Jan 2517
Jan 2517.02
Jan 2516.36
Jan 2516.76
Dec 2416.68
Dec 2416.76
Dec 2417.1
Dec 2417.22
Nov 2417.83
Nov 2417.65
Nov 2417.38
Nov 2418.2
Nov 2417.89
Oct 2418.1
Oct 2421.35
Price/Operating Cashflow
468101214med 8.78Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARE Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 267.53
Sep 267.75
Aug 267.59
Aug 267.88
Aug 267.09
Aug 267.32
Jul 266.91
Jul 266.84
Jul 266.74
Jul 266.43
Jul 267.06
Jun 267.42
Jun 266.85
Jun 267.14
Jun 266.89
May 266.67
May 266.5
May 266.04
May 266.21
May 265.56
Apr 265.71
Apr 265.86
Apr 265.13
Apr 265.21
Mar 265.55
Mar 265.71
Mar 265.83
Mar 266.11
Feb 266.51
Feb 266.46
Feb 266.33
Feb 266.74
Jan 266.58
Jan 267.38
Jan 267.16
Jan 266.67
Jan 266.06
Dec 256.01
Dec 255.93
Dec 255.77
Dec 255.62
Nov 256.64
Nov 256.29
Nov 256.47
Nov 256.88
Oct 257.2
Oct 259.28
Oct 258.99
Oct 258.86
Oct 2510.04
Sep 2510.05
Sep 2510.33
Sep 2510.18
Sep 2510.15
Aug 259.88
Aug 259.7
Aug 259.12
Aug 258.89
Aug 259.11
Jul 259.85
Jul 259.72
Jul 259.89
Jul 259.56
Jun 259.12
Jun 258.87
Jun 258.97
Jun 258.77
May 258.73
May 258.43
May 259.06
May 259.21
May 259.26
Apr 258.68
Apr 258.9
Apr 258.8
Apr 259.3
Mar 2510.93
Mar 2511.01
Mar 2511.34
Mar 2511.72
Feb 2511.69
Feb 2510.93
Feb 2510.85
Feb 2510.97
Jan 2511.13
Jan 2510.54
Jan 2510.56
Jan 259.85
Jan 2510.28
Dec 2410.2
Dec 2410.29
Dec 2410.65
Dec 2410.77
Nov 2411.43
Nov 2411.23
Nov 2410.95
Nov 2411.83
Nov 2411.5
Oct 2411.72
Oct 2413.1
Price to Book
0.20.40.60.81med 0.56Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARE Price to Book by quarter
PeriodPrice to Book
Sep 260.5
Sep 260.52
Aug 260.51
Aug 260.53
Aug 260.47
Aug 260.49
Jul 260.5
Jul 260.5
Jul 260.49
Jul 260.47
Jul 260.51
Jun 260.54
Jun 260.5
Jun 260.52
Jun 260.5
May 260.48
May 260.47
May 260.44
May 260.45
May 260.4
Apr 260.42
Apr 260.43
Apr 260.38
Apr 260.38
Mar 260.41
Mar 260.42
Mar 260.43
Mar 260.45
Feb 260.48
Feb 260.48
Feb 260.47
Feb 260.5
Jan 260.49
Jan 260.48
Jan 260.47
Jan 260.43
Jan 260.39
Dec 250.39
Dec 250.39
Dec 250.38
Dec 250.37
Nov 250.43
Nov 250.41
Nov 250.42
Nov 250.45
Oct 250.47
Oct 250.61
Oct 250.59
Oct 250.58
Oct 250.66
Sep 250.66
Sep 250.67
Sep 250.66
Sep 250.66
Aug 250.65
Aug 250.63
Aug 250.6
Aug 250.58
Aug 250.59
Jul 250.64
Jul 250.61
Jul 250.62
Jul 250.6
Jun 250.57
Jun 250.55
Jun 250.56
Jun 250.55
May 250.54
May 250.53
May 250.56
May 250.57
May 250.58
Apr 250.58
Apr 250.6
Apr 250.59
Apr 250.62
Mar 250.73
Mar 250.74
Mar 250.76
Mar 250.79
Feb 250.79
Feb 250.73
Feb 250.73
Feb 250.74
Jan 250.75
Jan 250.77
Jan 250.77
Jan 250.72
Jan 250.75
Dec 240.75
Dec 240.75
Dec 240.78
Dec 240.79
Nov 240.84
Nov 240.82
Nov 240.8
Nov 240.86
Nov 240.84
Oct 240.86
Oct 240.92
Alexandria Real Estate Equities, Inc.
ARE
Stockpicker

Video analysis: ARE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ARE

Alexandria Real Estate: Despite Headwinds, It Remains A Buy

seekingalpha.com · 13 Sep 2026

Alexandria Real Estate: Despite Headwinds, It Remains A Buy

Alexandria Real Estate Equities (ARE) remains a Buy, supported by a compelling margin of safety despite headwinds. ARE faces persistent supply-demand imbalances in key life science markets, but recent improvements in venture funding and leasing trends offer cautious optimism. Alexandria is responding defensively — asset sales, a 45% dividend cut, lower G&A, and a pivot to JV capital — as credit downgrades reflect the same headwinds already priced in.

Alexandria Real Estate: The Risk Was At $220, Not At $51

seekingalpha.com · 13 Sep 2026

Alexandria Real Estate: The Risk Was At $220, Not At $51

Alexandria Real Estate has declined 75% in five years due to oversupply, higher rates, and a biotech funding slowdown. Despite recent negative rental rate changes and falling occupancy, ARE's best-in-class assets are positioned for a flight to quality as supply dries up. Life sciences market fundamentals are stabilizing, with construction pipelines shrinking and key markets showing early signs of recovery.

Everyone Is Avoiding These REITs: That's The Opportunity

seekingalpha.com · 13 Sep 2026

Everyone Is Avoiding These REITs: That's The Opportunity

Some of the most hated REIT sectors may offer the biggest upside. European REITs trade at unusually steep NAV discounts. Life science and tower REITs could recover as sentiment turns.

Alexandria Real Estate Chief Accounting Officer Sells 10,000 Shares

fool.com · 9 Sep 2026

Alexandria Real Estate Chief Accounting Officer Sells 10,000 Shares

The Aug. 31 transaction was valued at $509,300. The sale involved shares equal to 9% of the stake held directly by the insider prior to the transaction.

Alexandria Real Estate Equities, Inc. $ARE Shares Bought by Hsbc Holdings PLC

defenseworld.net · 8 Sep 2026

Alexandria Real Estate Equities, Inc. $ARE Shares Bought by Hsbc Holdings PLC

Hsbc Holdings PLC grew its position in Alexandria Real Estate Equities, Inc. (NYSE: ARE) by 15.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,208,572 shares of the real estate investment trust's stock after buying an additional

Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Investments

prnewswire.com · 4 Sep 2026

Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Investments

PASADENA, Calif., Sept. 4, 2026 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science and advanced technology innovation clusters, today recognizes Blood Cancer Awareness Month by highlighting its strategic investments and tenants developing life-saving therapies in hematology and oncology, as well as the company's longstanding mission-critical engagement with the nation's leading nonprofits focused on blood cancers.

Alexandria Real Estate: We've Already Seen The Bottom, Next Is The Retest

seekingalpha.com · 4 Sep 2026

Alexandria Real Estate: We've Already Seen The Bottom, Next Is The Retest

Alexandria Real Estate Equities, Inc. (ARE) is deeply undervalued, but technical entry timing is critical for optimal returns. ARE's FFO faces near-term headwinds from major lease expirations in 2027, with recovery expected as new leases and projects ramp up. I target a $45 average entry, buying in tranches on further weakness or a breakout above $55, to balance value and momentum.

Alexandria Real Estate Equities (ARE) Up 5.7% Since Last Earnings Report: Can It Continue?

zacks.com · 2 Sep 2026

Alexandria Real Estate Equities (ARE) Up 5.7% Since Last Earnings Report: Can It Continue?

Alexandria Real Estate Equities (ARE) reported earnings 30 days ago. What's next for the stock?

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.